Xenogen Corporation


May 09, 06

NEW STORY
16:52 ET Xenogen Announces First Quarter 2006 Financial Results

 
Apr 03, 06

08:05 ET New Research Method Demonstrates Promise for Pancreatic Cancer Research and Drug Development

 
Mar 31, 06

08:00 ET Xenogen Expands Product Line With Introduction of New Optical Imaging System

 
Mar 02, 06

16:36 ET Xenogen Announces Record 2005 Revenue Up 28%

 
Feb 22, 06

19:44 ET Xenogen Announces 2005 Fourth Quarter and Full Year Financial Results Release Date and Conference Call

 
Dec 07, 05

08:02 ET Xenogen Announces Extension of Global Licensing Agreement

 
Nov 04, 05

06:30 ET Xenogen to Present at CIBC World Markets Healthcare Conference

 
Nov 03, 05

16:11 ET Xenogen Reports Third Quarter 2005 Financial Results

 
Oct 31, 05

13:59 ET Xenogen Announces 2005 Third Quarter Release Date and Conference Call

 
Oct 14, 05

06:30 ET Xenogen to Present at the 2005 BIO Investor Forum

 
Oct 13, 05

08:30 ET Xenogen Announces Second Agreement With Gene Logic

 
Sep 07, 05

08:01 ET Xenogen Launches First Commercial Three-Dimensional Biophotonic Imaging System

 
Aug 31, 05

16:05 ET Xenogen to Present at Thomas Weisel Partners Healthcare Conference

 
Aug 15, 05

19:25 ET Xenogen Completes $15 Million Private Equity Financing

 
Aug 11, 05

19:34 ET Xenogen to Raise $15 Million in Private Placement

 
Aug 08, 05

18:52 ET Xenogen Enters Into Agreements With Silicon Valley Bank and Partners for Growth for up to $18 Million of Debt Capital

 
Aug 04, 05

16:05 ET Xenogen Reports Second Quarter Total Revenue Up 30%

 
Jul 28, 05

06:31 ET Xenogen Announces 2005 Second Quarter Release Date and Conference Call

 
May 16, 05

08:31 ET Xenogen Releases 3D Software for its Proprietary Imaging Systems

 
May 11, 05

16:30 ET Xenogen Reports Record $9.3 Million Total Revenue in First Quarter

 
May 10, 05

16:05 ET Xenogen Files Answer and Counterclaims in Patent Infringement Litigation with AntiCancer Inc.

 
Apr 28, 05

06:31 ET Xenogen Announces 2005 First Quarter Release Date and Conference Call

 
Apr 21, 05

06:30 ET Xenogen Elects E. Kevin Hrusovsky to Board of Directors

 
Apr 12, 05

08:30 ET Xenogen Announces Licensing Agreement with MIR Preclinial Services

 
Mar 30, 05

06:30 ET Xenogen to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2006 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.